| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.32 | 7e-08 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.27 | 7e-07 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.22 | 6e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.24 | 9e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |